Cefixime Supplier-Buyer Network — Trade Flow Analysis

Name: Cefixime Supplier-Buyer Trade Network Dataset — 668+ Indian Exporters, 19+ Importers, 131+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cefixime supplier network, Cefixime buyers, pharmaceutical export India, Cefixime trade data

TransData Nexus

Cefixime

India Pharmaceutical Trade Intelligence

$173.9M668 Suppliers131 CountriesHS 30042019

ExportsIndia → FRANCE11.3%India → UNITED STATES7.1%

ImportsUNITED STATES → India$68.6K AUSTRIA → India$16.7K

#1 Supplier: MICRO LABS #1 Buyer: SAAM GROUP

Who Supplies Cefixime? Top Manufacturers & Buyers 2026 — MICRO LABS LIMITED Leads | TransData Nexus | TransData Nexus

1LUPIN LIMITED

LUPIN LIMITED is the first-largest Cefixime exporter from India, with a market share of 5.6% and a total export value of $9.8M across 83 shipments. Their average shipment value of $118.0K is above the market average of $20.7K, suggesting premium or bulk contract pricing.

LUPIN LIMITED serves 5 named buyers in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 91.2% of this supplier's tracked business. Top customers include:

• UPS SUPPLY CHAIN SOL — $8.9M across 76 shipments (91.2% of this supplier's total exports)

• NA — $479.2K across 4 shipments (4.9% of this supplier's total exports)

• MYIT MAHAR TRADING C — $167.8K across 1 shipments (1.7% of this supplier's total exports)

• BIOCARE PHARMACEUTIC — $162.7K across 1 shipments (1.7% of this supplier's total exports)

• TO THE ORDER — $48.0K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: LUPIN LIMITED's per-shipment value of $118.0K is 470% above the market average of $20.7K, consistent with large-order contracts or value-added formulations.

2MICRO LABS LIMITED

MICRO LABS LIMITED is the second-largest Cefixime exporter from India, with a market share of 5.5% and a total export value of $9.5M across 697 shipments. Their average shipment value of $13.6K is below the market average of $20.7K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AL-KAWKAB SCIENTIFIC BUREAU — $4.0M across 295 shipments (42.3% of this supplier's total exports)

• AL-KAWKAB SCIENTIFIC BUREAU — $2.9M across 216 shipments (31.0% of this supplier's total exports)

• LABOREX UGANDA LIMITED — $1.2M across 89 shipments (12.7% of this supplier's total exports)

• E.P.DIS — $819.5K across 60 shipments (8.6% of this supplier's total exports)

• HATAY PHARMACEUTICAL — $510.0K across 38 shipments (5.4% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (697 shipments) at a per-shipment value of $13.6K, indicating a broad distribution network with many smaller, regular orders.

3UNIVENTIS MEDICARE LIMITED

UNIVENTIS MEDICARE LIMITED is the third-largest Cefixime exporter from India, with a market share of 4.3% and a total export value of $7.5M across 50 shipments. Their average shipment value of $149.9K is above the market average of $20.7K, suggesting premium or bulk contract pricing.

UNIVENTIS MEDICARE LIMITED serves 2 named buyers in our database. SAAM GROUP LTD is the dominant customer, accounting for 98.6% of this supplier's tracked business. Top customers include:

• SAAM GROUP LTD — $7.4M across 49 shipments (98.6% of this supplier's total exports)

• SHAMS NOORI PHARMA T — $103.5K across 1 shipments (1.4% of this supplier's total exports)

Key Insight: UNIVENTIS MEDICARE LIMITED's per-shipment value of $149.9K is 624% above the market average of $20.7K, consistent with large-order contracts or value-added formulations.

4SAKAR HEALTHCARE LIMITED

SAKAR HEALTHCARE LIMITED is the fourth-largest Cefixime exporter from India, with a market share of 3.7% and a total export value of $6.5M across 91 shipments. Their average shipment value of $71.6K is above the market average of $20.7K, suggesting premium or bulk contract pricing.

SAKAR HEALTHCARE LIMITED serves 5 named buyers in our database. M/S. PRINCE PHARMA DEPOT PHARMACETI is the dominant customer, accounting for 89.4% of this supplier's tracked business. Top customers include:

• M/S. PRINCE PHARMA DEPOT PHARMACETI — $5.8M across 81 shipments (89.4% of this supplier's total exports)

• STE PRINCE PHARMA SA — $349.4K across 5 shipments (5.4% of this supplier's total exports)

• EUROASIA PHARMACEUTI — $156.7K across 2 shipments (2.4% of this supplier's total exports)

• PLANET PHARMA — $100.5K across 1 shipments (1.5% of this supplier's total exports)

• STE Prince Pharma SA — $83.5K across 1 shipments (1.3% of this supplier's total exports)

Key Insight: SAKAR HEALTHCARE LIMITED's per-shipment value of $71.6K is 246% above the market average of $20.7K, consistent with large-order contracts or value-added formulations.

5SAGA LIFESCIENCES LIMITED

SAGA LIFESCIENCES LIMITED is the fifth-largest Cefixime exporter from India, with a market share of 3.5% and a total export value of $6.0M across 47 shipments. Their average shipment value of $128.6K is above the market average of $20.7K, suggesting premium or bulk contract pricing.

SAGA LIFESCIENCES LIMITED serves 4 named buyers in our database. NA is the dominant customer, accounting for 96.5% of this supplier's tracked business. Top customers include:

• NA — $5.8M across 45 shipments (96.5% of this supplier's total exports)

• TO THE ORDER — $125.4K across 1 shipments (2.1% of this supplier's total exports)

• MANAGUA — $45.1K across 0 shipments (0.7% of this supplier's total exports)

• TO THE ORDER — $38.8K across 0 shipments (0.6% of this supplier's total exports)

Key Insight: SAGA LIFESCIENCES LIMITED's per-shipment value of $128.6K is 521% above the market average of $20.7K, consistent with large-order contracts or value-added formulations.

6AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Cefixime exporter from India, with a market share of 2.5% and a total export value of $4.4M across 192 shipments. Their average shipment value of $22.9K is above the market average of $20.7K, suggesting premium or bulk contract pricing.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MYLAN IRELAND LIMITED, — $1.5M across 67 shipments (35.1% of this supplier's total exports)

• AURO PHARMA INC, — $1.1M across 47 shipments (24.4% of this supplier's total exports)

• AURO PHARMA INC, — $903.9K across 39 shipments (20.5% of this supplier's total exports)

• ARROW GENERIQUES, — $539.7K across 24 shipments (12.3% of this supplier's total exports)

• AUROBINDO PHARMA USA — $334.6K across 15 shipments (7.6% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD's per-shipment value of $22.9K is 11% above the market average of $20.7K, consistent with large-order contracts or value-added formulations.

1France

France ranks as the first-largest destination for Cefixime imports from India, with a total trade value of $19.7M across 302 shipments — representing a 11.3% share of all Cefixime exports. The average shipment value of $65.1K is above the global average of $20.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Cefixime importers in France: PLANET PHARMA is the largest buyer, accounting for 13.1% ($2.6M) of this market's total imports.

• PLANET PHARMA — $2.6M (13.1% of France's total)

• PLANETPHARMA — $2.3M (11.5% of France's total)

• MYLAN IRELAND LIMITED, — $1.8M (9.3% of France's total)

Key Insight: France's per-shipment average of $65.1K (214% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

France is a key market for Cefixime imports from India.

Primary Market

Secondary Market

2United States

United States ranks as the second-largest destination for Cefixime imports from India, with a total trade value of $12.3M across 0 shipments — representing a 7.1% share of all Cefixime exports. The average shipment value of $12.3M is above the global average of $20.7K, indicating high-value procurement contracts or branded formulations.

Key Insight: United States's per-shipment average of $12.3M (59163% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cefixime imports from India.

Primary Market

Secondary Market

3Philippines

Philippines ranks as the third-largest destination for Cefixime imports from India, with a total trade value of $10.5M across 0 shipments — representing a 6.1% share of all Cefixime exports. The average shipment value of $10.5M is above the global average of $20.7K, indicating high-value procurement contracts or branded formulations.

Key Insight: Philippines's per-shipment average of $10.5M (50827% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Cefixime imports from India.

Primary Market

Secondary Market

4Afghanistan

Afghanistan ranks as the fourth-largest destination for Cefixime imports from India, with a total trade value of $10.3M across 48 shipments — representing a 5.9% share of all Cefixime exports. The average shipment value of $215.1K is above the global average of $20.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cefixime importers in Afghanistan: SAAM GROUP LTD is the largest buyer, accounting for 73.2% ($7.6M) of this market's total imports.

• SAAM GROUP LTD — $7.6M (73.2% of Afghanistan's total)

Key Insight: Afghanistan's per-shipment average of $215.1K (939% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Afghanistan is a key market for Cefixime imports from India.

Primary Market

Secondary Market

5Kenya

Kenya ranks as the fifth-largest destination for Cefixime imports from India, with a total trade value of $8.8M across 66 shipments — representing a 5.1% share of all Cefixime exports. The average shipment value of $134.0K is above the global average of $20.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cefixime importers in Kenya: LABOREX UGANDA LIMITED is the largest buyer, accounting for 18.8% ($1.7M) of this market's total imports.

• LABOREX UGANDA LIMITED — $1.7M (18.8% of Kenya's total)

Key Insight: Kenya's per-shipment average of $134.0K (547% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Kenya is a key market for Cefixime imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cefixime.
2.Flow Mapping: 668 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 8,398 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 131 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

8,398 Verified Shipments

668 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cefixime

Cefixime

Who Supplies Cefixime? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cefixime? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cefixime Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1LUPIN LIMITED

2MICRO LABS LIMITED

3UNIVENTIS MEDICARE LIMITED

4SAKAR HEALTHCARE LIMITED

5SAGA LIFESCIENCES LIMITED

6AUROBINDO PHARMA LTD

From Indian Factories to Global Pharmacies — How Cefixime Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cefixime Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1France

2United States

3Philippines

4Afghanistan

5Kenya

People Also Ask — Cefixime Supplier & Trade Network

Cefixime Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology